Clinical Trial Update: Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A randomized multicenter Phase 2/3 study compared docetaxel plus cisplatin and 5-FU to cisplatin plus 5-FU in advanced gastric cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Sanofi | Conditions: Stomach Neoplasm | Phase 2, Phase 3 | Status: COMPLETED